Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jeena Sikho LifecareNSE:JSLL +4.32%91 Intrinsic Value: Projected FCF is ₹76.96 as of Aug. 07, 2026, which is 100% below its 10-year median of 12.08. GuruFocus rates NSE:JSLL with a GF Score™ of 91/100 and a GF Value™ of ₹788.49 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 339 Healthcare Providers & Services companies, Jeena Sikho Lifecare ranks worse than 95.58% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
The historical rank and industry rank for Jeena Sikho Lifecare's Intrinsic Value: Projected FCF or its related term are showing as below:
NSE:JSLL'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 7.01 Med: 12.08 Max: 17.14
Current: 7.85
During the past 8 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Jeena Sikho Lifecare was 17.14. The lowest was 7.01. And the median was 12.08.
NSE:JSLL's Price-to-Projected-FCF is ranked worse than 95.58% of 339
companies
in the Healthcare Providers & Services industry
Industry Median: 1.07
vs NSE:JSLL: 7.85
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Jeena Sikho Lifecare's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
604.25
/
76.955359758585
=
7.85
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jeena Sikho Lifecare Intrinsic Value: Projected FCF Related Terms
Jeena Sikho Lifecare Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for Jeena Sikho Lifecare's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:JSLL vs HCA, THC, DVA: Intrinsic Value: Projected FCF Comparison
For the Medical Care Facilities subindustry, Jeena Sikho Lifecare's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeena Sikho Lifecare Price-to-Projected-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jeena Sikho Lifecare's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Jeena Sikho Lifecare's Price-to-Projected-FCF falls into.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of ₹76.96 mean?
Jeena Sikho Lifecare (NSE:JSLL) has a Intrinsic Value: Projected FCF of ₹76.96 as of Aug. 07, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Jeena Sikho Lifecare and its competitors. This is 537% above median its historical median of 12.08. Over the past decade, Jeena Sikho Lifecare's Intrinsic Value: Projected FCF has ranged from 7.01 to 17.14. According to the industry distribution chart, Jeena Sikho Lifecare ranks #324 out of 339 companies in the Healthcare Providers & Services industry, placing it in the top 95.6%.
Is Jeena Sikho Lifecare's Intrinsic Value: Projected FCF too high?
Jeena Sikho Lifecare's current Intrinsic Value: Projected FCF of ₹76.96 is 537% above median its 10-year median of 12.08. Over the past 10 years, this metric has ranged from a low of 7.01 to a high of 17.14. Based on the distribution chart, Jeena Sikho Lifecare ranks #324 out of 339 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Jeena Sikho Lifecare has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's Intrinsic Value: Projected FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jeena Sikho Lifecare ranks #324 out of 339 companies for Intrinsic Value: Projected FCF. This places Jeena Sikho Lifecare in the lower half of its industry. The industry median Intrinsic Value: Projected FCF is 1.07. Historically, Jeena Sikho Lifecare's own Intrinsic Value: Projected FCF has ranged from 7.01 to 17.14 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Healthcare Providers & Services company?
The median Intrinsic Value: Projected FCF among Healthcare Providers & Services companies is 1.07, based on 339 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Jeena Sikho Lifecare and its competitors. For the Healthcare Providers & Services industry, the median Intrinsic Value: Projected FCF is 1.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeena Sikho Lifecare's current Intrinsic Value: Projected FCF is ₹76.96, which is 537% above median its own 10-year median of 12.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹788.49, compared to a current price of ₹604.25 — trading 23.4% below its estimated fair value. The current Intrinsic Value: Projected FCF is ₹76.96, which is 537% above median its 10-year median of 12.08. Jeena Sikho Lifecare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current Intrinsic Value: Projected FCF is ₹76.96 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?
Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued.
The current stock price of ₹604.25 is trading 23.4% below its estimated GF Value™ of ₹788.49.
GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.
Key valuation signals for NSE:JSLL:
Intrinsic Value: Projected FCF: ₹76.96 (537% above median its 10-year median of 12.08)
GF Value™: ₹788.49 vs. price of ₹604.25 (23.4% below fair value)
No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
91GF Score
Get the complete analysis for NSE:JSLL
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JSLL has been successfully added to your 
